208 related articles for article (PubMed ID: 17804245)
1. Antiproliferative activity of chalcones with basic functionalities.
Liu X; Go ML
Bioorg Med Chem; 2007 Nov; 15(22):7021-34. PubMed ID: 17804245
[TBL] [Abstract][Full Text] [Related]
2. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
Loa J; Chow P; Zhang K
Cancer Chemother Pharmacol; 2009 May; 63(6):1007-16. PubMed ID: 18766342
[TBL] [Abstract][Full Text] [Related]
3. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative properties of piperidinylchalcones.
Liu X; Go ML
Bioorg Med Chem; 2006 Jan; 14(1):153-63. PubMed ID: 16185876
[TBL] [Abstract][Full Text] [Related]
6. Structural requirement of chalcones for the inhibitory activity of interleukin-5.
Yang HM; Shin HR; Cho SH; Bang SC; Song GY; Ju JH; Kim MK; Lee SH; Ryu JC; Kim Y; Jung SH
Bioorg Med Chem; 2007 Jan; 15(1):104-11. PubMed ID: 17064909
[TBL] [Abstract][Full Text] [Related]
7. MDR-reversal activity of chalcones.
Ivanova A; Batovska D; Engi H; Parushev S; Ocsovszki I; Kostova I; Molnar J
In Vivo; 2008; 22(3):379-84. PubMed ID: 18610751
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors.
Reddy NP; Aparoy P; Reddy TC; Achari C; Sridhar PR; Reddanna P
Bioorg Med Chem; 2010 Aug; 18(16):5807-15. PubMed ID: 20667741
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of synthesized 2'-oxygenated chalcone derivatives: modulation of human cell cycle phase distribution.
Rao YK; Fang SH; Tzeng YM
Bioorg Med Chem; 2004 May; 12(10):2679-86. PubMed ID: 15110849
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
Aponte JC; Verástegui M; Málaga E; Zimic M; Quiliano M; Vaisberg AJ; Gilman RH; Hammond GB
J Med Chem; 2008 Oct; 51(19):6230-4. PubMed ID: 18798609
[TBL] [Abstract][Full Text] [Related]
13. Antiprotozoal activity of chloroquinoline based chalcones.
Hayat F; Moseley E; Salahuddin A; Van Zyl RL; Azam A
Eur J Med Chem; 2011 May; 46(5):1897-905. PubMed ID: 21377771
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines.
Zsoldos-Mády V; Csámpai A; Szabó R; Mészáros-Alapi E; Pásztor J; Hudecz F; Sohár P
ChemMedChem; 2006 Oct; 1(10):1119-25. PubMed ID: 16944543
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of a series of tangeretin-derived chalcones.
Quintin J; Desrivot J; Thoret S; Le Menez P; Cresteil T; Lewin G
Bioorg Med Chem Lett; 2009 Jan; 19(1):167-9. PubMed ID: 19013795
[TBL] [Abstract][Full Text] [Related]
16. Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted.
Batovska D; Parushev S; Stamboliyska B; Tsvetkova I; Ninova M; Najdenski H
Eur J Med Chem; 2009 May; 44(5):2211-8. PubMed ID: 18584918
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of some polymethoxylated fused pyridine ring systems as antitumor agents.
Rostom SA; Hassan GS; El-Subbagh HI
Arch Pharm (Weinheim); 2009 Oct; 342(10):584-90. PubMed ID: 19714673
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological activity of chalcones derived from 2,4,6-trimethoxyacetophenone in RAW 264.7 cells stimulated by LPS: quantitative structure-activity relationships.
Chiaradia LD; dos Santos R; Vitor CE; Vieira AA; Leal PC; Nunes RJ; Calixto JB; Yunes RA
Bioorg Med Chem; 2008 Jan; 16(2):658-67. PubMed ID: 17988874
[TBL] [Abstract][Full Text] [Related]
19. Antiplasmodial activity of ferrocenyl chalcones: investigations into the role of ferrocene.
Wu X; Tiekink ER; Kostetski I; Kocherginsky N; Tan AL; Khoo SB; Wilairat P; Go ML
Eur J Pharm Sci; 2006 Feb; 27(2-3):175-87. PubMed ID: 16269240
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, SAR and antibacterial studies on novel chalcone oxazolidinone hybrids.
Selvakumar N; Kumar GS; Azhagan AM; Rajulu GG; Sharma S; Kumar MS; Das J; Iqbal J; Trehan S
Eur J Med Chem; 2007 Apr; 42(4):538-43. PubMed ID: 17150281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
